ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Rheumatology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,393Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 112

$1.34M Total Retail Price of All Prescriptions

Rank: 2 out of 112

634 Patients Receiving at Least One Drug in Part D
58%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 634 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

17% of this provider’s 634 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

6% of this provider’s 3,981 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$160 was the average price of a prescription from this provider, compared to $147 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
HYDROCODONE-ACETAMINOPHEN 892 344 S3 1 4
PREDNISONE 873 543 2 2
METHOTREXATE 716 504 3 1
TRAMADOL HCL 611 270 4 5
LEFLUNOMIDE 301 222 5 8
ENBREL 224 82 6 11
ZOLPIDEM TARTRATE 224 70 6 17
HYDROXYCHLOROQUINE SULFATE 191 99 8 3
CYMBALTA 169 58 9 16
CELEBREX 161 104 10 14
ETODOLAC 155 72 11 24
CYCLOBENZAPRINE HCL 154 36 R 12 10
GABAPENTIN 133 58 13 6
MELOXICAM 130 90 14 7
AMITRIPTYLINE HCL 127 78 R 15 42
OMEPRAZOLE 123 44 16 13
HUMIRA 120 32 17 15
CARISOPRODOL 117 68 R 18 32
TIZANIDINE HCL 113 42 19 22
OXYCODONE HCL 112 18 S2 20 84
IBUPROFEN 108 58 21 52
LYRICA 101 32 22 18
DICLOFENAC SODIUM 96 64 23 19
METHADONE HCL 88 21 S2 24 88
BACLOFEN 86 19 25 89
OXYCODONE-ACETAMINOPHEN 81 32 S2 26 20
OXYCONTIN 77 31 S2 27 73
NABUMETONE 70 43 28 25
PANTOPRAZOLE SODIUM 67 34 29 98
AZATHIOPRINE 64 23 30 28
VOLTAREN 64 28 30 35
ALENDRONATE SODIUM 57 47 32 12
PROMETHAZINE HCL 57 11 R 32 81
NAPROXEN 56 26 34 41
DOXEPIN HCL 56 26 34 118
NEXIUM 55 17 36 40
METHYLPREDNISOLONE 51 30 37 45
FENTANYL 50 13 S2 38 51
LIDODERM 50 18 38 58
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 6, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.